Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Tags
AMTE Power
Tag:
AMTE Power
Shares
AIM weekly movers: Mars bids for Hotel Chocolat
Andrew Hore
-
18/11/2023
0
Shares
AIM movers: Strong cash generation for Parkmead, shortage of cash for Real Good Food
Andrew Hore
-
17/11/2023
0
Shares
AIM movers: Barkby considers Cambridge Sleep sale
Andrew Hore
-
16/09/2023
5
Shares
AIM weekly movers: Infrastructure India selling main asset
Andrew Hore
-
08/09/2023
6
Shares
AIM weekly movers: Itsarm bounces back
Andrew Hore
-
29/07/2023
0
Shares
AIM movers: Actual Experience contract and Great Western Mining fundraising
Andrew Hore
-
26/07/2023
0
Shares
AIM weekly movers: OptiBiotix Health sweetener
Andrew Hore
-
22/07/2023
1
Shares
AIM movers: Filtronic ESA contract and Bowleven still planning fundraising
Andrew Hore
-
21/07/2023
0
Shares
AIM movers: Brand Architekts cutting losses and ex-dividends
Andrew Hore
-
20/07/2023
0
Premium
Powering up production without draining the batteries
Andrew Hore
-
13/07/2023
0
1
2
3
Page 1 of 3
Most Read
AIM weekly movers: Marechale Capital gains FCA approval
14/06/2026
Aquis weekly movers: energy B buys Horse Hill oil field stake
14/06/2026
FTSE 100 jumps as Trump signals peace deal
12/06/2026
AIM Movers: Virgin Wines forecast loss raised and Medpal AI set to grow following oral GLP-1 approval
12/06/2026